TNFRSF4 Kit CLIA
-
- Antigène Voir toutes TNFRSF4 Kits CLIA
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Reactivité
- Souris
- Méthode de détection
- Chemiluminescent
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 15.62 pg/mL - 1000 pg/mL
- Seuil minimal de détection
- 15.62 pg/mL
- Application
- ELISA
- Fonction
- Mouse Tumor Necrosis Factor Receptor Superfamily Member 4 (TNFRSF4) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
- Type d'échantillon
- Plasma, Serum, Tissue Homogenate
- Analytical Method
- Quantitative
- Sensibilité
- < 6.7 pg/mL
- Featured
- Discover our best selling TNFRSF4 Kit ELISA
- Top Product
- Discover our top product TNFRSF4 Kit ELISA
-
-
- Indications d'application
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Date de péremption
- 6 months
-
- Antigène Voir toutes TNFRSF4 Kits CLIA
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
- Autre désignation
- TNFRSF4 (TNFRSF4 Produits)
- Synonymes
- TNFRSF4 Kit CLIA, ACT35 Kit CLIA, CD134 Kit CLIA, Ly-70 Kit CLIA, Ox40 Kit CLIA, TXGP1L Kit CLIA, Txgp1 Kit CLIA, OX40 Kit CLIA, TNF receptor superfamily member 4 Kit CLIA, tumor necrosis factor receptor superfamily, member 4 Kit CLIA, TNFRSF4 Kit CLIA, Tnfrsf4 Kit CLIA
- Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-